Skip to main content
Clinical Trials/NCT05912257
NCT05912257
Recruiting
N/A

Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery

VA Office of Research and Development1 site in 1 country188 target enrollmentMay 1, 2024
ConditionsCancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
VA Office of Research and Development
Enrollment
188
Locations
1
Primary Endpoint
6-Minute Walk Change
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

In this pragmatic clinical trial, the investigators will study older Veterans approaching surgery for gastrointestinal or genitourinary cancer who are at high risk for a marked decline in their physical function. The investigators will test a multi-targeted nutrition regimen high in protein and other key nutrients and including resistance exercise, administered 8 weeks prior to surgery and for 24 weeks after discharge from surgery, with the goal of protecting physical function and improving physiologic, metabolic, and patient-centered outcomes. The findings of this study will promote a better intervention to compensate for the high nutritional demands of cancer and its treatment and lead to stronger, more rapid physical recoveries and better quality of life for older adults with moderate to advanced cancer-a group that has rarely been included in long-term nutrition studies. In addition to providing direct benefits to Veterans, the study may also benefit the VA by decreasing demands on the health care system via hastening the recovery of physical function.

Detailed Description

The overall objective of this study is to administer the nutrition optimization of senior health (NOSH) intervention in biphasic intervals and compare it to a typically recommended nutrition regimen (Typical Regimen) for (1) physical function, (2) physiologic and metabolic outcomes; and (3) Veteran-centered outcomes. The central hypothesis is that NOSH will improve physical function. The investigators also predict improvements in physiologic, metabolic and Veteran-centered outcomes. The investigators seek an optimal intervention to alleviate symptom burden and improve function, health, and QoL for older cancer survivors, and the long-term goal is to confirm and implement this intervention. The primary aim is to evaluate the efficacy of a multi-targeted NOSH intervention on physical function. Based on preliminary data, the investigators' working hypothesis is that the NOSH intervention will result in improved physical function before surgery and after surgery relative to the (Typical Regimen).

Registry
clinicaltrials.gov
Start Date
May 1, 2024
End Date
June 1, 2027
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male and Female Veterans
  • Stage I, II, III cancer of the bladder, colon, kidney, liver, pancreas, stomach or rectum
  • Surgery 6 weeks from consent
  • Age \> 60 years
  • Age-normal renal function
  • English speaking
  • Able to record dietary intake or has a proxy who can record dietary intake
  • Willing and able to be randomized to either intervention group

Exclusion Criteria

  • Stage IV cancer diagnosis
  • Glomerular filtration rates (GFR) less than 45 mL/min
  • Neurological conditions causing functional impairments, including Parkinson's disease, multiple sclerosis, and permanent disability due to stroke
  • Class III-IV congestive heart failure
  • Refractory cachexia - medical condition that affects ability to increase muscle mass (e.g., cachexia) defined as 10% weight loss in 10 months, 5% weight loss in 6 months or 2% weight loss over any period plus body mass index 20 kg/m2 AND Life expectancy 9 months
  • Active treatment for another cancer site
  • Body weight \>450 lbs
  • Uncontrolled diabetes (HbA1c 9%)
  • Recent diagnosis of thyroid disease or untreated thyroid disease
  • Inability to complete physical function assessment

Outcomes

Primary Outcomes

6-Minute Walk Change

Time Frame: baseline, within 24 hours before surgery, 30-days post-op, 12-weeks following post-op visit, 24 weeks following post-op visit

Distance walked in 6 minute.

Secondary Outcomes

  • Health-related QoL (QLQ-C30)(baseline, within 24 hours before surgery, 30-days post-op, 12-weeks following post-op visit, 24 weeks following post-op visit)
  • Patient Generated-Subjective Global Assessment (PG-SGA)(baseline, within 24 hours before surgery, 30-days post-op, 12-weeks following post-op visit, 24 weeks following post-op visit)

Study Sites (1)

Loading locations...

Similar Trials